Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-055970
Filing Date
2026-05-13
Accepted
2026-05-13 17:27:34
Documents
2
Period of Report
2026-05-13

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0290713-6k_akanda.htm 6-K 15097
2 NOTICE OF ADJOURNED SPECIAL MEETING OF SHAREHOLDERS ea029071301ex99-1.htm EX-99.1 24988
  Complete submission text file 0001213900-26-055970.txt   41152
Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Filer) CIK: 0001888014 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41324 | Film No.: 26974732
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)